ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2026)
ENDRA Life Sciences (NDRA) reported Total Non-Current Liabilities of $815857.0 for Q1 2026, down 4.23% year-over-year from $851928.0 in Q1 2025, and down 3.19% quarter-over-quarter from $842721.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 8 years of Total Non-Current Liabilities data on file, last reported at $815857.0 in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $815857.0, down 4.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $815857.0 (down 4.23% YoY), and the FY2025 annual result was $842721.0, down 34.51% from the prior year.
- Total Non-Current Liabilities slipped to $815857.0 in Q1 2026 per NDRA's latest filing, from $842721.0 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.3 million in Q4 2024 and troughed at $98421.0 in Q2 2024.
- A 5-year average of $628945.5 and a median of $786870.5 in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities slumped 47.51% in 2023, then soared 670.04% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $365919.0 in 2022, then tumbled by 47.51% to $192062.0 in 2023, then jumped by 569.97% to $1.3 million in 2024, then plunged by 34.51% to $842721.0 in 2025, then dropped by 3.19% to $815857.0 in 2026.
- Business Quant data shows NDRA's Total Non-Current Liabilities at $815857.0 in Q1 2026, $842721.0 in Q4 2025, and $992421.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 22.71 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 737.18 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.42 Bn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 815,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 815,857.00 |
| Dec 31, 2025 | 842,721.00 |
| Sep 30, 2025 | 992,421.00 |
| Jun 30, 2025 | 757,884.00 |
| Mar 31, 2025 | 851,928.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 960,379.00 |
| Jun 30, 2024 | 98,421.00 |
| Mar 31, 2024 | 145,825.00 |
| Dec 31, 2023 | 192,062.00 |
| Sep 30, 2023 | 237,163.00 |
| Dec 31, 2022 | 365,919.00 |
| Mar 31, 2021 | 280,829.00 |
| Dec 31, 2020 | 608,992.00 |
| Sep 30, 2020 | 627,573.00 |
| Jun 30, 2020 | 645,450.00 |
| Mar 31, 2020 | 325,804.00 |
| Dec 31, 2019 | 342,812.00 |
| Sep 30, 2019 | 358,915.00 |